Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S ANALYSIS
5 REGULATORY FRAMEWORK
5.1 REGULATORY GUIDANCE AS PER U.S. FDA.
5.2 REGULATORY SCENARIO FOR EUROPEAN UNION
5.3 REGULATORY SCENARIO IN JAPAN
5.4 REGULATORY FRAMEWORK IN CHINA
6 PIPELINE ANALYSIS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 PRODUCT APPROVAL OF SMALL MOLECULE
7.1.3 HIGH R&D INVESTMENT FOR SMALL MOLECULE DEVELOPEMNT
7.1.4 STRONG PIPELINE FOR SMALL MOLECULE INJECTABLE
7.1.5 GROWTH IN GENERIC INJECTABLES
7.2 RESTRAINTS
7.2.1 HIGH LEVEL OF QUALITY AND CARE REQUIRED IN THE PRODUCTION
7.2.2 HIGH MANUFACTURING AND PURCHASING COST OF INJECTABLES
7.2.3 STRINGENT REGULATIONS FOR FACILITES AND EQUIPMENTS REQUIRED FOR SMALL MOLECULES INJECTABLE
7.2.4 PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
7.3.2 GROWING PRODUCT LAUNCHES
7.3.3 RISING PER CAPTIA INCOME AND HEALTHCARE EXPENDITURE
7.4 CHALLENGES
7.4.1 LACK OF ACCESSIBILITY
7.4.2 HIGH COST OF DIAGNOSIS & TREATMENT
8 IMPACT OF COVID-19 ON THE EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET
8.1 OVERVIEW AFTERMATH OF COVID-19 AND GOVERNMENT ROLE
8.2 IMPACT ON PRICE
8.3 IMPACT ON DEMAND
8.4 IMPACT ON SUPPLY CHAIN
8.5 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
8.6 CONCLUSION
9 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 VIAL FILLING
9.3 SYRINGE FILLING
9.4 CARTRIDGE FILLING
9.5 OTHERS
10 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ONCOLOGY
10.3 INFECTIOUS DISEASES
10.4 CARDIOVASCULAR DISEASES
10.5 METABOLIC DISEASES
10.6 NEUROLOGY
10.7 UROLOGY
10.8 DERMATOLOGY
10.9 AUTOIMMUNE DISEASES
10.1 RESPIRATORY DISORDERS
10.11 OTHERS
11 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 SPECIALTY CLINICS
11.4 HOMECARE SETTING
11.5 OTHERS
12 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.4 ONLINE PHARMACY
12.5 OTHERS
13 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 FRANCE
13.1.3 U.K.
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 NETHERLANDS
13.1.7 RUSSIA
13.1.8 SWITZERLAND
13.1.9 BELGIUM
13.1.10 TURKEY
13.1.11 SWEDEN
13.1.12 DENMARK
13.1.13 POLAND
13.1.14 REST OF EUROPE
14 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 PFIZER INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.2 GILEAD SCIENCES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 TEVA PHARMACEUTICAL INDUSTRIES LTD.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FRESENIUS KABI USA (ASUBSIDIARY OF FRESENIUS SE & CO. KGAA).
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 ABBVIE INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 AMERICAN REGENT, INC. (A DAIICHI SANKYO GROUP COMPANY)
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 AMGEN INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 AMOMED PHARMA GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 ASTRAZENECA
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 BIOCRYST PHARMACEUTICALS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 BRISTOL-MYERS SQUIBB COMPANY
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENTS
16.12 EISAI CO., LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 EXELIXIS, INC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 GENENTECH, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENTS
16.15 HIKMA PHARMACEUTICALS PLC
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 MERCK SHARP & DOHME CORP., A SUBSIDIARY OF MERCK & CO., INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 NEUREN PHARMACEUTICALS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 NOXOPHARM
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 SANOFI
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENT
16.2 TELIGENT
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCT PORTFOLIO
16.20.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, PIPELINE ANALYSIS
TABLE 2 NUMBER OF PEOPLE WITH DIABETES (MILLION) AMONG AGES 20–79 YEARS
TABLE 3 PER CAPITA AMOUNTS: UNITED STATES (1960–2017 YEARS)
TABLE 4 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 5 EUROPE VIAL FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 EUROPE SYRINGE FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 EUROPE CARTRIDGE FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 EUROPE OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 EUROPE ONCOLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 EUROPE INFECTIOUS DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 EUROPE CARDIOVASCULAR DISEASE IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 EUROPE METABOLIC DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 EUROPE NEUROLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 EUROPE UROLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 EUROPE DERMATOLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 EUROPE AUTOIMMUNE DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 EUROPE RESPIRATORY DISORDERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 EUROPE OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 EUROPE HOSPITALS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 EUROPE SPECIALTY CLINICS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 EUROPE HOMECARE SETTING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 EUROPE OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 26 EUROPE DIRECT TENDER IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 EUROPE RETAIL PHARMACY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 EUROPE ONLINE PHARMACY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 EUROPE OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 32 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 33 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 35 GERMANY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 GERMANY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 37 GERMANY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 GERMANY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 39 FRANCE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 40 FRANCE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 FRANCE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 42 FRANCE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 U.K. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 44 U.K. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 U.K. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 46 U.K. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 47 ITALY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 48 ITALY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 ITALY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 ITALY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 SPAIN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 52 SPAIN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 53 SPAIN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 SPAIN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 NETHERLANDS SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 NETHERLANDS SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 NETHERLANDS SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 NETHERLANDS SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 59 RUSSIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 60 RUSSIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 61 RUSSIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 RUSSIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 63 SWITZERLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 64 SWITZERLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 SWITZERLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 SWITZERLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 67 BELGIUM SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 68 BELGIUM SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 BELGIUM SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 BELGIUM SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 TURKEY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 72 TURKEY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 TURKEY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 74 TURKEY SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 75 SWEDEN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 76 SWEDEN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 SWEDEN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 SWEDEN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 79 DENMARK SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 80 DENMARK SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 DENMARK SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 82 DENMARK SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 83 POLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 84 POLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 POLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 POLAND SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 87 REST OF EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION
FIGURE 2 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: EUROPE VS. REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: PRODUCT LIFELINE CURVE
FIGURE 8 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DBMR MARKET POSITION GRID
FIGURE 10 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: MARKET END USER COVERAGE GRID
FIGURE 12 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION
FIGURE 13 THE GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE IMMUNOASSAYS-GAMMA COUNTER MARKET
FIGURE 16 THE GRAPH BELOW SHOWS THE INCREASING PREVALENCE OF CHRONIC DISEASES IN 1995 TO FORECAST 2030 IN THE U.S.
FIGURE 17 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, 2020
FIGURE 18 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, 2021-2028 (USD MILLION)
FIGURE 19 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 20 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, 2020
FIGURE 22 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 23 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 24 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, 2020
FIGURE 26 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 27 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 28 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 29 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 30 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 31 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 32 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SNAPSHOT (2020)
FIGURE 34 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2020)
FIGURE 35 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 36 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT (2021-2028)
FIGURE 38 EUROPE SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: COMPANY SHARE 2020 (%)
